News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Millennium Pharmaceuticals, Inc. CEO Out as Takeda Pharmaceutical Co. Ltd. (TKPYY) Reorganizes, Cuts Costs


5/10/2013 7:29:50 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Deborah Dunsire, the CEO who led Millennium Pharmaceuticals to prominence in cancer treatment, is leaving the company in an abrupt departure five years after it was acquired by Japan-based Takeda Pharmaceuticals. Dunsire exits as the company is seeking to merge operations around the globe and cut costs as it braces for a sales decline. Anna Protopapas, a Takeda executive vice president of business development who has been with the company since 1997, will replace Dunsire as president of Takeda’s Cambridge, MA-based cancer operation, effective immediately. Dunsire will also depart from Takeda’s board of directors at next month’s board meeting, just one year after she joined the board.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy
Read at Boston Globe

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES